biopharmconsortium.blogspot.com
Biopharmconsortium BlogExpert commentary from Haberman Associates biotechnology and pharmaceutical consulting.
http://biopharmconsortium.blogspot.com/
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting.
http://biopharmconsortium.blogspot.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
3.4 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
19
SSL
EXTERNAL LINKS
1
SITE IP
172.217.6.65
LOAD TIME
3.365 sec
SCORE
6.2
Biopharmconsortium Blog | biopharmconsortium.blogspot.com Reviews
https://biopharmconsortium.blogspot.com
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting.
biopharmconsortium.blogspot.com
Biopharmconsortium Blog: January 2010
http://biopharmconsortium.blogspot.com/2010_01_01_archive.html
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Thursday, January 28, 2010. Update on liraglutide (Novo Nordisk’s Victoza)—approved by the FDA for treatment of type 2 diabetes. On October 25, 2009, we posted an article. On January 26, 2010, after a 21-month review, the FDA approved liraglutide for treatment of type 2 diabetes. This followed the approval of the drug in Japan a week earlier. As a result, the drug’s label carries a black box warning of the risk ...
Biopharmconsortium Blog: December 2009
http://biopharmconsortium.blogspot.com/2009_12_01_archive.html
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Thursday, December 31, 2009. Cancer metabolism as a target for drug discovery: Agios Pharmaceuticals. In the December 10 2009 issue of Nature. Researchers at Agios Pharmaceuticals (Cambridge, MA) and their academic collaborators published an article. Implicating mutations in a metabolic enzyme, cytosolic isocitrate dehydrogenase (IDH1) as a causative factor in a major subset of human brain cancers. According to the au...
Biopharmconsortium Blog: February 2010
http://biopharmconsortium.blogspot.com/2010_02_01_archive.html
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Friday, February 19, 2010. Across-the-board R&D cuts will not solve the pharmaceutical industry’s productivity crisis. The big topic in pharmaceutical news lately has been layoffs, including layoffs due to major cuts in R&D. For example, the popular pharmaceutical industry blog “In the Pipeline”. The more fundamental reason that motivates large pharmaceutical companies to enter into big mergers and/or to undertake res...
Biopharmconsortium Blog: November 2009
http://biopharmconsortium.blogspot.com/2009_11_01_archive.html
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Friday, November 27, 2009. Stapled peptides for targeting intracellular signaling pathways: research and commercial development. In the 12 November issue of Nature. There was a research article. And a News and Views minireview. About targeting an intracellular signaling pathway with a novel type of compound called a stapled peptide. However, the 12 November Nature. The signaling pathway that is the focus of this artic...
Biopharmconsortium Blog: July 2009
http://biopharmconsortium.blogspot.com/2009_07_01_archive.html
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Tuesday, July 28, 2009. Now for some chemistry—Natural Products. In the 10 July issue of Science, Jesse W.-H. Li and John C. Vederas of the University of Alberta reviewed the current state of natural products-based drug discovery and development, in a report entitled “Drug Discovery and Natural Products: End of an Era or an Endless Frontier? Among the technologies that the authors discuss is an application of syntheti...
TOTAL PAGES IN THIS WEBSITE
19
Top 50 Biotechnology Blogs – The BioBlogging Project
http://mastersinbiotechnology.com/2010/top-50-biotechnology-blogs
Blogging about biotech, science, and genetics. Top 50 Biotechnology Blogs. May 25, 2010. Today, many biotechnology blogs focus on genomics. Especially personal genomics) and the business side of biotech. The blogs listed below are produced by professors, students. As well as law firms and researchers. One other focus in these top 50 biotechnology blogs is bioinformatics, represented in both in molecular biology as well as in databases, algorithms, computational and statistical techniques and theory.
TOTAL LINKS TO THIS WEBSITE
1
Home
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. For more information please contact . Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms. To find out more information.
biopharm2-kinshasa
Biopharmconllc.com
ExecServices
Is a National Full Service Recruiting Organization. Functional expertise encompasses Business Development, Clinical Research, Commercial, Drug Safety, Marketing, Medical/Scientific Affairs and Regulatory Affairs. Because this is our only business, we are able to find and attract the most qualified candidates for your open positions. Reduced Time to Hire, Increased Quality of Candidates and Reduced Cost per Hire. Are three of the most widely tracked metrics in our industry today. With BioPharmConnect.
biopharmconsortium.blogspot.com
Biopharmconsortium Blog
Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting. Friday, June 11, 2010. Haberman Associates' Biopharmconsortium Blog has moved to our own site. You can now find it at http:/ biopharmconsortium.com/blog. Please go to the new site, which has many new posts on it. We invite you to keep reading our blog, to subscribe to it, and to make useful comments to our blog posts if you so desire. Allan B Haberman, Ph.D. Links to this post. Saturday, June 5, 2010. We hope that you...
Haberman Associates – Consulting for Effective Life Science R&D and Partnering
Consulting for Effective Life Science R&D and Partnering. About Allan B. Haberman, Ph.D. About Allan B. Haberman, Ph.D. From drug discovery research . . . We can help you navigate your path to more productive R and D. Consulting for effective life science R&D and partnering. Is a Boston-based consulting firm, founded in 1993, that specializes in science and technology strategy for biotechnology, pharmaceutical, and other life science companies. Clients have used our consulting services to help them:.
BioPharmConsult AG - Management and Engineering Services
*** DomainRegistry.com Inc. ***
By DomainRegistry.Com Inc. CouponBook.com - Coupons, Discounts. BusinessForms.com - Business Forms.
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
biopharmcro.com - Registered at Namecheap.com
This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.
